While these TIGIT positive T cells showed immune dysfunction and reduced glycometabolic activity, the treatment with TIGIT antibody could reverse the immune failure of these cells, inhibit tumor progression and induce tumor cell apoptosis. This evidence concerns the gene TIGIT and neoplasm.